Medical Devices
Technology
Health

Smith & Nephew

$39.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.03%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Smith & Nephew and other stocks, options, ETFs, and crypto commission-free!

About

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It offers the following products and services: sports medicine joint repair; arthroscopic enabling technologies; trauma and extremities; other surgical businesses; knee and hip implants, and advanced wound care, wound bioactives, and wound devices. Read More It operates through the United Kingdom, United States of America, and Other geographical segments. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Employees
16,377
Headquarters
London, London & South East
Founded
1937
Market Cap
17.33B
Price-Earnings Ratio
26.23
Dividend Yield
1.87
Average Volume
620.01K
High Today
$39.70
Low Today
$39.43
Open Price
$39.63
Volume
95.80K
52 Week High
$40.78
52 Week Low
$32.22

Collections

Medical Devices
Technology
Health
Medical
Advertising and Marketing
Sports
Business Services
Entertainment

News

Yahoo FinanceMar 13

Smith & Nephew POLAR3™ Total Hip Solution demonstrates best-in-class results from world's largest registry

LONDON, March 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas presented data around its POLAR3 Total Hip Solution.

10
ReutersMar 13

UPDATE 1-UK Stocks-Factors to watch on March 13

(Adds company news items and futures) March 13 (Reuters) - Britain’s FTSE 100 is seen opening 18 points lower at 7,133 on Wednesday, according to financial bookmakers, while FTSE 100 futures were down 0.42 percent ahead of the cash market open. * AVAST: Cyber security firm Avast’s long-time chief executive officer is stepping down, the company said on Wednesday as it reported marginally lower-than-expected adjusted revenue and earnings in its first annual results since listing in May. * PROVIDENT FINANCI...

0
Markets InsiderMar 12

Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business

LONDON, March 12, 2019 /PRNewswire/ -- Brainlab, the global pioneer of software-driven medical technology, and Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announce that Smith & Nephew has agreed to acquire the Brainlab orthopaedic joint reconstruction business.

15

Earnings

$0.00
$0.29
$0.59
$0.88
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available May 2, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.